Itraconazole
"Itraconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
| Descriptor ID |
D017964
|
| MeSH Number(s) |
D03.383.129.799.550 D03.383.606.530
|
| Concept/Terms |
Sporanox- Sporanox
- Janssen Brand of Itraconazole
- Itraconazole Janssen Brand
Orungal- Orungal
- Janssen-Cilag Brand of Itraconazole
- Janssen Cilag Brand of Itraconazole
|
Below are MeSH descriptors whose meaning is more general than "Itraconazole".
Below are MeSH descriptors whose meaning is more specific than "Itraconazole".
This graph shows the total number of publications written about "Itraconazole" by people in this website by year, and whether "Itraconazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Itraconazole" by people in Profiles.
-
Grennan D, Alvi S, Jhaveri MD, Lin MY, Wiet RM. Complicated Blastomycosis of the Skull Base Presenting as Otitis Media. JAMA Otolaryngol Head Neck Surg. 2020 01 01; 146(1):81-82.
-
Bayers SL, Arkin L, Bohaty B, Paller AS. Neurotoxicity in the setting of pediatric atopic dermatitis treated with modified cyclosporine and itraconazole. J Am Acad Dermatol. 2013 Oct; 69(4):e177-8.
-
Proia LA, Harnisch DO. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother. 2012 Jul; 56(7):4029.
-
Thanasumpun T, Batra PS. Oral antifungal therapy for chronic rhinosinusitis and its subtypes: a systematic review. Int Forum Allergy Rhinol. 2011 Sep-Oct; 1(5):382-9.
-
Quinney SK, Galinsky RE, Jiyamapa-Serna VA, Chen Y, Hamman MA, Hall SD, Kimura RE. Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats. Drug Metab Dispos. 2008 Jun; 36(6):1097-101.